Login to your account

Username *
Password *
Remember Me
Bibliographie

Bibliographie (2546)

Long Covid: Study shows persistence of symptoms in a third of ambulatory patients 30 to 45 days after diagnosis

vendredi, 11 décembre 2020 11:49 Écrit par

COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings – Annals of Internal Medicine Commentary: COVID-19: persistent symptoms in one third of cases – Université de Genève   Commentary on Twitter Study of 669 people who had #COVID19 during the first wave in Switzerland. Of 510 who were followed up for 30-45 days, 32% still […]

The post Long Covid: Study shows persistence of symptoms in a third of ambulatory patients 30 to 45 days after diagnosis appeared first on Links Medicus.

Just published: Pfizer vaccine confers 95% protection against Covid-19

vendredi, 11 décembre 2020 11:49 Écrit par

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine – New England Journal of Medicine Editorial: SARS-CoV-2 Vaccination — An Ounce (Actually, Much Less) of Prevention Commentary: Pfizer vaccine results published in peer-reviewed journal – MedicalXpress Related: FDA advisory panel endorses Pfizer/BioNTech Covid-19 vaccine – STAT   Commentary on Twitter (Thread – Click for more) […]

The post Just published: Pfizer vaccine confers 95% protection against Covid-19 appeared first on Links Medicus.

UK to refine allergy warning on Pfizer vaccine sparked by two adverse reactions

jeudi, 10 décembre 2020 10:13 Écrit par

UK to refine allergy warning on Pfizer vaccine sparked by two adverse reactions – Reuters See also: UK probes whether COVID-19 vaccine caused allergic reactions – Associated Press AND NHS told not to give Covid vaccine to those with history of allergic reactions – The Guardian  

The post UK to refine allergy warning on Pfizer vaccine sparked by two adverse reactions appeared first on Links Medicus.

Systematic review: Men with COVID-19 have almost three times the risk of requiring ICU admission and a higher risk of death

jeudi, 10 décembre 2020 10:13 Écrit par

Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission – Nature Medicine Commentary: Men face ‘almost three times the odds’ of ICU admission for Covid-19, study says – CNN AND Men with COVID-19 three times more likely to need intensive care: study – MedicalXpress   Commentary on Twitter […]

The post Systematic review: Men with COVID-19 have almost three times the risk of requiring ICU admission and a higher risk of death appeared first on Links Medicus.

CDC releases new ventilation guidelines for indoor environments to reduce Covid-19 risk

mercredi, 09 décembre 2020 10:22 Écrit par

CDC Releases New Ventilation Guidelines For Indoor Environments To Reduce Covid-19 Risk – Forbes CDC Guideline: Ventilation Related podcast: Air Handling Standards for Increasing the Safety of Indoor Spaces During the COVID-19 Pandemic – JAMA  

The post CDC releases new ventilation guidelines for indoor environments to reduce Covid-19 risk appeared first on Links Medicus.

Another randomized trial shows hydroxychloroquine is not effective as postexposure prophylaxis to prevent Covid-19

mercredi, 09 décembre 2020 10:22 Écrit par

Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Randomized Trial – Annals of Internal Medicine Summary for patients: Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection  

The post Another randomized trial shows hydroxychloroquine is not effective as postexposure prophylaxis to prevent Covid-19 appeared first on Links Medicus.

Just published: AstraZeneca-Oxford Covid-19 vaccine shows moderate efficacy, but questions remain about the most effective dosing regimen

mercredi, 09 décembre 2020 10:22 Écrit par

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK – The Lancet Commentaries: Oxford COVID vaccine paper highlights lingering unknowns about results – Nature AND Detailed data on AstraZeneca-Oxford Covid-19 vaccine show it has moderate efficacy – STAT […]

The post Just published: AstraZeneca-Oxford Covid-19 vaccine shows moderate efficacy, but questions remain about the most effective dosing regimen appeared first on Links Medicus.

Recherche